The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries

Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy

(2016) Florenzo Iannone et al.   AUTOIMMUNITY REVIEWS

Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis

(2015) David Ternant et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis

(2015) David Ternant et al.   CLINICAL PHARMACOKINETICS

Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients

(2015) Florenzo Iannone et al.   JOINT BONE SPINE

The association between chronic pain and obesity

(2015) Akiko Okifuji et al.   Journal of Pain Research

Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis

(2014) Lihi Eder et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriatic arthritis: current therapy and future approaches

(2014) D. Huynh et al.   RHEUMATOLOGY

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO

(2014) B. Glintborg et al.   RHEUMATOLOGY

Body weight, gender and response to TNF-  blockers in axial spondyloarthritis

(2014) E. Gremese et al.   RHEUMATOLOGY

Relationships between Adipose Tissue and Psoriasis, with or without Arthritis

(2014) Éric Toussirot et al.   Frontiers in Immunology

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers

(2013) Matteo Nicola Dario Di Minno et al.   ANNALS OF THE RHEUMATIC DISEASES

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

(2013) David Ternant et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The link between obesity and psoriatic arthritis

(2012) Juan D Cañete et al.   ANNALS OF THE RHEUMATIC DISEASES

Obesity and the risk of psoriatic arthritis: a population-based study

(2012) Thorvardur Jon Love et al.   ANNALS OF THE RHEUMATIC DISEASES

Obesity and risk of incident psoriatic arthritis in US women

(2012) Wenqing Li et al.   ANNALS OF THE RHEUMATIC DISEASES

Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity

(2012) Lihi Eder et al.   ANNALS OF THE RHEUMATIC DISEASES

The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis

(2012) Sandra Garcês et al.   ANNALS OF THE RHEUMATIC DISEASES

A Novel Anti-inflammatory Role for Spleen-Derived Interleukin-10 in Obesity-Induced Inflammation in White Adipose Tissue and Liver

(2012) K. Gotoh et al.   DIABETES

Obesity and C-reactive protein in various populations: a systematic review and meta-analysis

(2012) J. Choi et al.   Obesity Reviews

Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management

(2012) A. Russolillo et al.   RHEUMATOLOGY

Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy

(2012) F Iannone et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Obesity and the prediction of minimal disease activity: A prospective study in psoriatic arthritis

(2012) Matteo Nicola Dario di Minno et al.   ARTHRITIS CARE & RESEARCH

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine

(2012) Elisa Gremese et al.   ARTHRITIS CARE & RESEARCH

A possible role of leptin-associated increase in soluble interleukin-2 receptor diminishing a clinical response to infliximab in rheumatoid arthritis: Comment on the article by Klaasen et al

(2011) Jae Il Shin et al.   ARTHRITIS AND RHEUMATISM

Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis

(2011) Vito Di Lernia et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Differences in body mass index among individuals with PsA, psoriasis, RA and the general population

(2011) V. M. Bhole et al.   RHEUMATOLOGY

Body mass index and clinical response to infliximab in rheumatoid arthritis

(2010) Ruth Klaasen et al.   ARTHRITIS AND RHEUMATISM

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

(2010) Bente Glintborg et al.   ARTHRITIS AND RHEUMATISM

Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy

(2010) F. Bardazzi et al.   Dermatologic Therapy

Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation

(2010) Samuel Bremmer et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy

(2010) S Coimbra et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Depression and anxiety among US adults: associations with body mass index

(2009) G Zhao et al.   INTERNATIONAL JOURNAL OF OBESITY

Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

(2008) T R D J Radstake et al.   ANNALS OF THE RHEUMATIC DISEASES